The Benedict Cassen Prize is awarded in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science. The prize award is $25,000 and is only offered every other year (even years).
This prestigious prize is named in honor of the late physicist Benedict Cassen, whose invention, the rectilinear scanner, first brought the ability to image patients to nuclear medicine. His widow, Mary Wylie Cassen, made a bequest to the Foundation to establish a major award. The awarding of this prize is in recognition of outstanding achievement is essential to encourage development and growth in nuclear medicine.
1994 – Hal O. Anger, B.S., D.Sc. (Hon.), for his invention of the scintillation camera.
1996 – David E. Kuhl, M.D., for his development of emission reconstruction tomography and quantitative measurements of brain physiology.
1998 – Henry N. Wagner, Jr., M.D., for his many contributions to Nuclear Medicine as a scientist, teacher and clinician.
2000 – Sally J. DeNardo, M.D., and Gerald L. DeNardo, M.D., for their fundamental contributions to present and future medical care through work in developing radiolabelled antibodies and contributions to the radioimmunotherapy of cancer.
2002 – Michael E. Phelps, PhD., for his exceptional involvement and work to translate PET science into clinical medical practice.
2004 – Michael J. Welch, PhD., for his work on rapid synthesis of positron-labeled organic chemicals which were of vital importance in the application of PET technology’s application to diagnostic medicine.
2006 – Alexander Gottschalk, M.D., for his pioneer work in the clinical applications of the Anger gamma camera and the use of Technetium radiotracers.
2008 – Mathew Thakur, PhD., for his original and major advances in the development of novel radiopharmaceuticals that have led nuclear medicine to play a major role in the management of patients with infections, vascular thromboembolism, and cancer.
2010 – Sung-Cheng (Henry) Huang, D.Sc., for his scholarship in applying biomathematics to the development & application of tracer kinetic models used as imaging assays of biological process in vivo with PET, from basic to clinical sciences.
2012 – Abass Alavi, MD, MD(Hon), PhD(Hon), DSc(Hon), for his contributions to the development of modern imaging techniques including Positron Emission Tomography, as revolutionary tools for conducting basic science research and improving patient care.
2012 – Steven M. Larson, M.D., for his research and leadership that have advanced nuclear medicine science, especially in uses of radionuclides for diagnosis and treatment of cancer.
2014 – Barry A. Siegel, M.D., for his sustained contributions to clinical translation of nuclear medicine science and, in particular, his visionary leadership in developing scientific methodology for evidence-based clinical trials that resulted in widespread acceptance of imaging studies using positron emission tomography.
2016 – H. William Strauss, M.D., in recognition of his seminal studies in cardiovascular nuclear medicine. These studies have greatly advanced nuclear medicine science and have had exceptionally high clinical impact.
2018 – Sanjiv Sam Gambhir, M.D., Ph.D., in recognition of his visionary leadership and rigorous science in developing and translating strategies for the imaging of human diseases using novel multimodality reporter genes and imaging agents.
2020 – Peter S. Conti, MD, PhD, in recognition of his pioneering work in the development of novel radiopharmaceuticals and clinical PET applications for cancer imaging, as well as his volunteerism and service to the molecular imaging community.
The Benedict Cassen Postdoctoral Fellowship
This grant was established by the Estates of Benedict Cassen and Mary Wiley Balfour Cassen to provide early-career scientists with mentoring experience and the opportunity to develop preliminary data for federal or other competitive research support. The grant will provide support for the postdoctoral fellow to carry out the research under the supervision of the junior faculty member with the assistance of a senior faculty member or principal investigator.
2014 – Marc David Normandin, PhD, Instructor of Radiology, Harvard Medical School Assistant in Physics, Massachusetts General Hospital, Department of Radiology.
Georges El Fakhri, PhD, DABR, Director, Center for Advanced Medical Imaging Sciences (CAMIS), Co-Director, Division of Nuclear Medicine & Molecular Imaging, Professor of Radiology Harvard Medical School is Dr. Normandin’s advisor.
2015 – Kyle Lapidus, MD, PhD, Assistant Professor, Director of Neuromodulation, Stony Brook University, Department of Psychiatry.
Ramin Parsey, MD, PhD, Professor and Chair of the Department of Psychiatry, Director of PET Research, Stoney Brook School of Medicine, is advisor to Dr. Lapidus.
2018 – Amy M. Fowler, M.D., Ph.D., University of Wisconsin, School of Medicine and Public Health, Department of Radiology, Breast Imaging Section
Jamey Weichert, PhD, Associate Professor in the Department of Radiology and Director of the UW-Madison Contrast Agent Laboratory is Dr. Fowler’s advisor.
2021 – Pedram Heidari, MD, Nuclear Medicine Specialist, Harvard Medical School, Department of Radiology, Massachusetts General Hospital
Umar Mahmood, MD, PhD. Associate Chair of Radiological Sciences, Director, Center for Precision Imaging, Professor of Radiology, Harvard Medical School is advisor to Dr. Heidari.
NET RF/ERF Nuclear Medicine Pilot Research Grant
2016 Thomas A. Hope, MD, for “Intra-Arterial Peptide Receptor Radionuclide Therapy (IA-PRRT) using 90Y-DOTA-TOC.”
2017 Babak Behnam Azad, PhD, for “An improved approach for detection and therapeutic monitoring of neuroendocrine tumors by PET.”
2018 Tara E. Mastren, PhD, for “Functionalized Silica Nanoparticles: Development of a Combined PET and TAT Theranostic Agent for Neuroendocrine Tumors.”
2019 Susanne Kossatz, PhD, for “Uncovering the cellular mechanisms that limit clinical application of PRRT.”
2021 Prof. Dr. Apr. Frederik Cleeren for “Targeted alpha therapy of NETs using somatostin-based radiopharmaceuticals with improved tumor-to-kidney ratio, the theranostic approach.”
Heather Jacene for“Imaging Androgen Receptors in Breast Cancer with 18F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study”
2021-2022 Mitzi & William Blahd, MD, Pilot Research Grant
Min-Jeong Kim, MD, PhD
Michael J. Welch, PhD Award
Victor Pike, PhD
Michael J. Welch, PhD, Postdoctoral Award
Erik Jimmy Jackobson
ERF SNMMI-TS Advanced Degree Scholarship
Sarah Gibbons, CNMT
ERF SNMMI-TS Bachelor’s Degree or Entry Level Master’s Degree Completion Scholarship
Derrick Gillan, ARRT(N)(MR)(CT)PET
Paul Cole Student Technologist Scholarships
Bradley-Alavi Student Fellowships
Servando Hernandez Vargas
ERF-SNMMI CMIIT Lab Professional
ERF-SNMMI Journal of Nuclear Medicine Technologists Best Paper
Paul E. Christian
Arthur Weis, MD Award in Radiation Dosimetry and Safety
ERF-SNMMI Young Investigator Awards Mohammad Naghavi-Behzad
ERF-SNMMI-TS and Student Professional Development Grant Awards for the SNMMI Annual Meeting
Samar El Khatib
C. David Gilmore
ERF/SNMMI COVID-19 Best Abstract (physician/scientist) Award
ERF/SNMMI COVID-19 Best Abstract (technologist) Award
ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty
Courtney Lawhn-Heath, MD
Susan C. Weiss Clinical Advancement Scholarship
Sarah Frye, CNMT
ERF-SNMMI Young Investigator Awards
Hazem Ahmed, PhD
Inna H. Gertsenshteyn
Theresa P. Devasia
Petra Lovrec, MD
Justus Baumgarten, MD
Emma M. Coomans
Felicitas J. Detmer
Elena Maria Zannoni
Lalith K. Shiyam Sundar
ERF-SNMMI Postdoctoral Molecular Imaging Scholar Program
Ashwin Singh Parihar
2021 Alavi–Mandell Awards for Articles Published in 2020
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients
Elliot M. Abbott
Quantitative 3D Assessment of 68Ga-DOTATOC PET/MRI with Diffusion-Weighted Imaging to Assess Imaging Markers for Gastroenteropancreatic Neuroendocrine Tumors: Preliminary Results
Lisa C. Adams
Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Surgical Perspective
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
Martin K. Bakht
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction
First Evidence for a Dose–Response Relationship in Patients Treated with 166Ho Radioembolization: A Prospective Study
Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit–Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer
64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen
3D-Printable Platform for High-Throughout Small-Animal Imaging
Lukas M. Carter
Combination Strategies to Improve Targeted Radionuclide Therapy
Tiffany G. Chan
18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis
Bao Ying Chen
Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET–Positive Osseous Lesions in Prostate Cancer
Le Wen Chiu
PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer
Tahleesa J. Cuda
Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study
68Ga-PSMA–Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer
Anouk C. de Jong
Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer
Steven J. de Jongh
Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
Paul L. de Zwart
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
Clinical Translation of a 68Ga-Labeled Integrin αvβ6–Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer
Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia
John M. Floberg
Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure
High-Throughput PET/CT Imaging Using a Multiple-Mouse Imaging System
Hannah E. Greenwood
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide
Kelly E. Henry
Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye–Protein Interaction
Albertus W. Hensbergen
177Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE
Folate Receptor β–Targeted PET Imaging of Macrophages in Autoimmune Myocarditis
Neuroinflammation PET Imaging: Current Opinion and Future Directions
Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer
Bernard H.E. Jansen
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H.E. Jansen
Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and 18F-FDG PET/CT in Correlation with Clinical Pathologic Outcome
Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT
Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
High-Resolution Depth-Encoding PET Detector Module with Prismatoid Light-Guide Array
PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Multiparametric 18F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?
18F-FDG PET/CT Identifies Predictors of Survival in Patients with Locally Advanced Cervical Carcinoma and Paraaortic Lymph Node Involvement to Allow Intensification of Treatment
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung
The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging
Yun Rose Li
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT
177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma
Marion M. Malenge
Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
Daniela D. Maltais
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J
PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations
An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
Christian A. Mason
Standardization of Preclinical PET/CT Imaging to Improve Quantitative Accuracy, Precision, and Reproducibility: A Multicenter Study
Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?
Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation
Robert J.H. Miller
Repurposing Molecular Imaging and Sensing for Cancer Image–Guided Surgery
Suman B. Mondal
18F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders
Filipe M. Montes de Jesus
Imaging Responses to Immunotherapy with Novel PET Tracers
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
So Won Oh
18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria
Inflammation-Based Index and 68Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC
PET/CT Imaging with an 18F-Labeled Galactodendritic Unit in a Galectin-1–Overexpressing Orthotopic Bladder Cancer Model
Patricia M.R. Pereira
Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions
Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
Kelsey L. Pomykala
First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
Edwin C. Pratt
Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRI
Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies
Zachary T. Rosenkrans
Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
Projection Space Implementation of Deep Learning–Guided Low-Dose Brain PET Imaging Improves Performance over Implementation in Image Space
Preclinical PERCIST and 25% of SUVmax Threshold: Precision Imaging of Response to Therapy in Co-clinical 18F-FDG PET Imaging of Triple-Negative Breast Cancer Patient–Derived Tumor Xenografts
Madhusudan A. Savaikar
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
PET Imaging of the Natural Killer Cell Activation Receptor NKp30
Travis M. Shaffer
Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism
18F-FDG PET/CT in Left-Ventricular Assist Device Infection: Initial Results Supporting the Usefulness of Image-Guided Therapy
Jan M. Sommerlath Sohns
Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn
18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
Thijs S. Stutvoet
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases
Eveline A. van de Stradt
Development and Evaluation of Interleukin-2–Derived Radiotracers for PET Imaging of T Cells in Mice
Elly L. van der Veen
Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT
Joyce van Sluis
Image Quality and Activity Optimization in Oncologic 18F-FDG PET Using the Digital Biograph Vision PET/CT System
Joyce van Sluis
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
Donatienne Van Weehaeghe
Management of Patients with Renal Failure Undergoing Dialysis During 131I Therapy for Thyroid Cancer
Diagnostic Value of 68Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study
A Prospective, Comparative Study of Ventilation–Perfusion Planar Imaging and Ventilation–Perfusion SPECT for Chronic Thromboembolic Pulmonary Hypertension
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
Rudolf A. Werner
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study
Shin Hye Yoo
Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging
177Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET